Cisplatin other names
WebJan 7, 2024 · Cisplatin is a prescription medication used to treat Metastatic Testicular Tumors, Advanced Bladder Cancer, and Metastatic Ovarian Carcinoma . Cisplatin is … WebDec 1, 2024 · Methods. In this open-label, randomized, phase III study, newly diagnosed patients with advanced NSCLC were initially randomized (R1, 1:1) to receive first-line treatment with cisplatin 75 mg/m 2 plus docetaxel 75 mg/m 2 (DC75) or 60 mg/m 2 (DC60) for up to 4 cycles. Patients without progression were further randomized (R2, 1:2) to best …
Cisplatin other names
Did you know?
WebSep 27, 2024 · Giving radiation therapy, cisplatin, and cetuximab may work better in treating patients with HPV positive, KRAS-variant oropharyngeal squamous cell carcinoma compared to radiation therapy and cisplatin alone. Show detailed description Study Design Go to Resource links provided by the National Library of Medicine WebCisplatin is an antineoplastic agent that is FDA approved for the treatment of metastatic testicular tumors, metastatic ovarian tumors, and advanced bladder cancer. There is a Black Box Warning for this drug as shown here. Common adverse reactions include anemia, leukopenia, and thrombocytopenia . Adult Indications and Dosage
WebOct 13, 2024 · Drug Information available for: Cisplatin Genetic and Rare Diseases Information Center resources: Vulvar Cancer U.S. FDA Resources Arms and Interventions Go to Outcome Measures Go to Primary Outcome Measures : Groin recurrence rate [ Time Frame: Within first 2 years after primary treatment ] WebNov 12, 2024 · Cisplatin Intravenous (Advanced Reading) Other brands Platinol, Platinol-AQ Professional resources Prescribing Information Related treatment guides Bladder Cancer Anal Cancer Blood Cell Transplantation Bone Marrow Transplantation References
WebOct 6, 2014 · Chemotherapy (Gemcitabine and Cisplatin) Surgical Resection and Lymphadenectomy Radiation Therapy Study Design Go to Resource links provided by the National Library of Medicine MedlinePlus Genetics related topics: Cholangiocarcinoma Drug Information available for: Cisplatin Gemcitabine Gemcitabine hydrochloride Web1. INTRODUCTION. Lung cancer has a high worldwide prevalence and is usually malignant, with the highest cancer‐related mortality. 1 , 2 Lung cancers can be grossly classified into non‐small cell lung carcinoma (NSCLC), accounting for about 85% of lung cancers, and small cell lung carcinoma, which is less prevalent. NSCLC can be further divided into …
WebCisplatin is a chemotherapy drug. You might have it as a treatment for a number of different types of cancer. You might have cisplatin on its own or in combination with other cancer …
WebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have … principality\\u0027s n5Webcisplatin (Rx) Brand and Other Names: Classes: Antineoplastics, Alkylating; Antineoplastics, Platinum Analog Print Dosing & Uses AdultPediatricGeriatric Dosage Forms & Strengths injectable... principality\u0027s n0WebCisplatin (sis-PLA-tin) Cisplatin is a chemotherapy drug that contains the metal platinum. It stops or slows growth of cancer cells and other cells that grow rapidly by damaging their … principality\\u0027s n7WebFeb 1, 2024 · Cisplatin (Intravenous Route) Description and Brand Names Drug information provided by: IBM Micromedex US Brand Name Platinol-AQ Descriptions … principality\u0027s nWebcisplatin systemic Brand names: Platinol, Platinol-AQ Drug class: alkylating agents Cisplatin systemic is used in the treatment of: Anal Cancer Bladder Cancer Blood Cell Transplantation Bone Marrow Transplantation Brain … plunge saw or circular sawWebNov 2, 2024 · Platinum-based chemotherapy can be effective in treating many different types of cancer. For example, cisplatin is one of the most effective drugs for ovarian … principality\\u0027s n1WebDec 24, 2009 · To compare the disease control rates of different doses of Docetaxel+Cisplatin as first-line treatment according to Response Evaluation Criteria In Solid Tumors (RECIST) criteria; To evaluate the overall response rate (ORR); To evaluate the time to disease progression (TTP); To evaluate the overall survival (OS); To evaluate … plunge sb into sth